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ABSTRACT 
Objective: Plants of the genus Dalbergia are reported to be useful in the treatment of arthritis, gonorrhoea and rheumatic pains. Present study was 
aimed to investigate the in vitro anti-inflammatory activity of ethanol extract from Dalbergia sissoo leaves (EDS) and to support its traditional use.  
Methods: EDS was investigated for it's in vitro anti-inflammatory activity in human red blood cell membrane stabilization (HRBC) method and 
protein denaturation method. Diclofenac sodium was used as the standard drug. 
Results: The EDS and diclofenac sodium showed a concentration dependent stabilization toward HRBC membrane with 314.3±0.01 and 34.91±0.01 
µg/ml; 50% protection, respectively. EDS and diclofenac sodium also showed dose dependent protein denaturation with IC50
Conclusions: EDS possessed noticeable in vitro anti-inflammatory effect against the HRBC membrane stabilization method and denaturation of 
albumin. Further authoritative studies are necessary to make certain the mechanisms and constituents behind its anti-inflammatory actions. 
 values 719.9±0.04 and 
428.4±0.02 µg/ml, respectively. 
Keywords: Dalbergia sissoo, In vitro anti-inflammatory models, HRBC membrane stabilization, Protein denaturation. 
 
Inflammation is a normal protective response to tissue injury caused 
by physical trauma, noxious chemical or microbial agents. It is the 
body's response to inactivate or destroy the invading organisms, to 
remove the irritants, and set the stage for tissue repair. It is 
triggered by liberating chemical mediators or signaling molecules 
from injured tissue and migrating cells [1]. The mechanism of 
inflammation is attributed, in part, to release of reactive oxygen 
species from activated neutrophil and macrophages. This 
overproduction leads to tissue injury by damaging the 
macromolecule and lipid peroxidation of membranes [2]. 
Dalbergia sissoo Roxb. ex DC. (D. sissoo) additionally, called Indian 
Rosewood (family: Fabaceae), a deciduous tree, occurs throughout the 
Sub-Himalayan tract from the Indus to Assam, and in the Himalayan 
valleys, ascending up to about 1500 m. Plants of the genus, Dalbergia is 
reported to be useful for the treatment of arthritis, gonorrhoea and 
rheumatic pains. Analgesic, antipyretic and anti-inflammatory activity 
of D. sissoo has been studied on different animal models [3, 4]. Leaves 
of the plant have the potency to inhibit diarrhoea and peristalsis [5]. D. 
sissoo plant is known to possess diverse phytochemical, most of which 
are observed to have health benefits. The leaves are known to contain 
biochanin A 7-O-[β-D-apiofuranosyl-(1→6)-β-D-glucopyranoside] [6] 
and biochanin A 7-O-[β-D-apiofuranosyl-(1→5)-β-D-apiofuranosyl-
(1→6)-β-D-glucopyranoside] [7]. A water-soluble polysaccharide was 
purified and isolated from D. sissoo leaves [8].  
Recently, traditional medicine worldwide has been re-evaluated by 
extensive research on different plant species and their active 
therapeutic principles. Medicinal plants are proved to be useful for 
the management of many inflammatory diseases and are usually 
devoid of serious adverse effects [9]. The present study was aimed 
to evaluate anti-inflammatory activity of ethanol extract from 
Dalbergia sissoo (EDS) by using in vitro models.  
The leaves of D. sissoo were collected from the lands of Balchandpur 
(Uttar Pradesh, India) in June 2011. Plant materials were 
taxonomically identified and authenticated by Dr Anamika Tripathi, 
Associate Professor, Hindu College, Moradabad, Uttar Pradesh, India, 
as D. sissoo Roxb. ex DC. with registration no. HC/Bot/PERL-25. 
Leaves of D. sissoo were washed with distilled water (H2
In vitro anti-inflammatory activity was extensively studied by the 
human red blood cell (HRBC) membrane stabilization method [10, 
11]. In this; blood was collected from a human volunteer who had 
not taken any non steroidal anti-inflammatory drugs (NSAIDs) for 
two weeks prior to this experiment and mixed with equal volume of 
Alsever solution (2% dextrose, 0.8% sodium citrate, 0.5% citric acid 
and 0.42% NaCl). The resulting volume was centrifuged at 3000 
rpm. The packed cells were washed with isosaline (0.9% w/v NaCl), 
and a 10% suspension was made. The reaction mixtures consist of 
the EDS with different concentration (25, 50, 100, 200, 400 and 800 
μg/ml) and to each concentration one ml phosphate buffer, 2 ml 
hyposaline, and 0.5 ml HRBC suspensions were added. These were 
incubated at 37 °C for 30 min and centrifuged at 3000 rpm for 20 
min. The haemoglobin content in the supernatant solution was 
estimated spectrophotometrically in triplicates at 560 nm. Diclofenac 
sodium with different concentration (10, 20, 40, 60, 80 and 100 
μg/ml) was used as the reference standard and a control was prepared 
without the extract or standard. The percentage haemolysis was 
calculated by assuming the haemolysis produced within the control 
group as 100%. The percentage of HRBC membrane stabilization or 
protection was calculated using the formula:  
Percentage Protection = 




remove dirt. It was further shade-dried and after that coarsely 
powdered. This coarse powder was defatted with petroleum ether, 
and subsequently extracted with ethanol using soxhlet apparatus 
(Borosil, India). The extract was concentrated at reduced 
temperature and pressure using a rotary evaporator. A yield for 
ethanol extract was found as 13.19% (w/w). EDS was further 
investigated for anti-inflammatory activity through lysosomal 
membrane stabilization (HRBC membrane stabilization method) and 
protein denaturation method as in vitro models.  
The reaction mixture (5 ml) consisted of 0.2 ml of egg albumin (from 
fresh hen's egg), 2.8 ml of phosphate-buffered saline (PBS, pH 6.4) 
and 2 ml of varying concentrations of EDS so that final 
concentrations became 50, 100, 200, 400, 800 and 1600 µg/ml. A 
similar volume of double- distilled water served as the control. Next, 
the mixtures were incubated at 37±2 °C in a BOD incubator for 15 
min and then heated at 70 °C for five minutes. After cooling, their 
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absorbance was measured in triplicates at 660 nm (SHIMADZU, UV 
1800) by using the vehicle as blank. Diclofenac sodium in the final 
concentrations (50, 100, 200, 400, 800 and 1600 µg/ml) were used 
as the reference drug and treated similarly for the determination of 
absorbance in triplicates [1]. The percentage inhibition of protein 
denaturation was calculated by using the following formula:  
Percentage Inhibition = 
Absorbance of test-Absorbance of control
Absorbance of control
×100 
The extract concentration for 50% inhibition (IC50
The result from the HRBC membrane stabilization method was 
shown in fig. 1 and fig. 2. The EDS showed a concentration 
dependent anti inflammatory activity, and the protection percent 
increased by an increase as the concentration of the EDS. From the 
dose-response curve, plotted as log [EDS (µg/ml)] against 
percentage response keeping the haemolysis produced within the 
control group as 100%, 50% percentage response were found at 
314.3±0.01 µg/ml and similarly, for diclofenac sodium it was 
34.91±0.01 µg/ml. 
) was determined 
by the dose-response curve.  
 
 
Fig. 1: Dose response curve for EDS in human red blood cell 
(HRBC) membrane stabilization method (n=3) 
 
 
Fig. 2: Dose response curve for Diclofenac Sodium in human red 
blood cell (HRBC) membrane stabilization method (n=3) 
 
EDS showed a dose dependent protein denaturation or stabilization 
throughout concentration range, i.e., 50, 100, 200, 400, 800 and 
1600 µg/ml towards denaturation of egg albumin (fig. 3). The 
diclofenac sodium also showed the dose depended inhibition of 
protein denaturation in the range 50, 100, 200, 400, 800 and 1600 
µg/ml and presented in the fig. 4. The IC50
The EDS exhibited membrane stabilization effect by inhibiting 
hypotonicity induced lysis of erythrocyte membrane. The 
erythrocyte membrane is analogous to the lysosomal membrane 
[12], and its stabilization implies that the EDS may as well stabilize 
lysosomal membrane [13]. Injury to lysosomal membrane usually 
triggers the release of phospholipase A
 values for EDS and 
diclofenac sodium are presented in the table 1.  
2
 
 that mediate the hydrolysis of 
phospholipids to produce inflammatory mediators [14]. Stabilization 
of the membranes from these cells inhibits lysis and subsequent 
release of the cytoplasmic contents which in turn limits the tissue 
damage and exacerbation of the inflammatory response. This might 
have contributed to the anti-inflammatory activity of the EDS. 
 




Fig. 4: Dose response curve for Diclofenac Sodium in protein 
denaturation method (n=3) 
 
Table 1: The IC50
Treatment 
 values for EDS and Diclofenac sodium in 
protein denaturation method (n=3) 
IC50 (µg/ml) 
EDS 719.9±0.04 
Diclofenac Sodium 428.4±0.02 
 
Protein denaturation method was selected for in vitro assessment of 
anti-inflammatory property of EDS. Denaturation of tissue proteins 
is one of the well-documented causes of inflammatory diseases. 
Production of autoantigens in said diseases may be due to 
denaturation of proteins in vivo [15, 16]. Agents, who can prevent 
protein denaturation, would be worthwhile for anti-inflammatory 
drug development. The increments in absorbances of test samples 
with respect to control samples indicate stabilization of protein, 
which implies the inhibition of heat-induced protein (albumin) 
denaturation by EDS and diclofenac sodium [1]. It has been reported 
that one of the features of several non-steroidal anti-inflammatory 
drugs is their ability to stabilize (prevent denaturation) heat treated 
albumin at the physiological pH (6.2-6.5) [17]. Hajare et al. [3, 4] 
studied the anti-inflammatory activity for the D. sissoo by conducting 
animal experiments, and in the relationship of our in vitro findings of 
the human red blood cell (HRBC) membrane stabilization method 
and denaturation of albumin.  
CONCLUSION 
Therefore, from the results of the present preliminary study, it can 
be resulted that EDS possessed noticeable in vitro anti-inflammatory 
Sachan et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 5, 105-107 
 
107 
effect against the human red blood cell (HRBC) membrane 
stabilization method and denaturation of albumin. Further 
authoritative studies are necessary to make certain to the 
mechanism and constituents behind its anti-inflammatory actions.  
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